Clinical Trials Directory

Trials / Completed

CompletedNCT05385562

Formulated PSTA Injection Versus PATA Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions

Formulated Posterior Subtenon Triamcinolone (PSTA) Injection Versus Posterior Subtenon Triamcinolone Alone in the Management of Macular Edema Secondary to Non-ischemic Retinal Vein Occlusions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
78 (actual)
Sponsor
Al-Azhar University · Academic / Other
Sex
All
Age
40 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to compare formulated Posterior Subtenon Triamcinolone acetonide (PSTA) injection versus Posterior Subtenon Triamcinolone acetonide alone in the management of macular edema secondary to non-ischemic retinal vein occlusions, either central or branch.

Conditions

Interventions

TypeNameDescription
DRUGTriamcinolone Acetonide and sodium hyaluronate and chondroitin sulfateformulated with sodium hyaluronate and chondroitin sulfate
DRUGTriamcinolone Acetonide aloneTriamcinolone Acetonide alone

Timeline

Start date
2020-01-02
Primary completion
2022-05-01
Completion
2022-05-10
First posted
2022-05-23
Last updated
2022-05-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05385562. Inclusion in this directory is not an endorsement.